| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024674 |
| Receipt No. | R000028388 |
| Official scientific title of the study | Effect of consecutive ingestion of Moringa oleifera leaves on improving constipation. |
| Date of disclosure of the study information | 2016/11/01 |
| Last modified on | 2017/01/05 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effect of consecutive ingestion of Moringa oleifera leaves on improving constipation.
|
|
| Title of the study (Brief title) | Effect of ingestion of Moringa oleifera leaves on improving constipation.
|
|
| Region |
|
|
| Condition | ||
| Condition | Healthy adult female with a tendency for constipation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of consecutive ingestion of Moringa oleifera leaves on improving constipation. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Defecation days,defecation frequency,fecal amount |
| Key secondary outcomes | Fecal shape,fecal color,fecal odor,feeling after defecation,intestinal microflora |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects ingested the placebo powder for 2 weeks, after 2 weeks, ingested the Moringa oleifera leaves powder for 2 weeks. | |
| Interventions/Control_2 | The subjects ingested the Moringa oleifera leaves powder for 2 weeks, after 2 weeks, ingested the placebo powder for 2 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.Subjects whose defecation frequency is no fewer than 3, nor more than 6,
2.Subjects who not consume higher amount of alcohol 3.Subjects whose meal times are three a day usually. |
|||
| Key exclusion criteria | 1.Subjects who regularly use intestinal drug and laxatives(including strong laxatives).
2.Subjects who can not stop intake higher amount of food containing viable bacteria such as Lactic acid bacteria, Bifidobacteria, Natto bacteria and/or the health food to relieve constipation during the screening period. 3.Subjects who has a medical history of diseases or surgery affecting digestion, absorption and bowel movement. 4.Subjects who is pregnant or willing to be pregnant or breast-feeding during this study. 5.Subjects who are judged unsuitable for this study by test responsibility doctor. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Mihoko Moto |
| Organization | Wayo Women's University |
| Division name | Department of Health and Nutrition |
| Address | 2-3-1 konodai, Ichikawa, Chiba, 272-8533 Japan |
| TEL | 047-371-2393 |
| moto@wayo.ac.jp | |
| Public contact | |
| Name of contact person | Mihoko Moto |
| Organization | Wayo Women's University |
| Division name | Department of Health and Nutrition |
| Address | 2-3-1 konodai, Ichikawa, Chiba, 272-8533 Japan |
| TEL | 047-371-2393 |
| Homepage URL | |
| moto@wayo.ac.jp | |
| Sponsor | |
| Institute | Wayo Women's University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | iGUAZU Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028388 |